Glaxosmithkline Pharmaceuticals informs about details of loss of certificate

20 Jun 2024 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder. They shall issue the Letter of Confirmation only after the necessary formalities are carried out by the Shareholder.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2360.05 -19.80 (-0.83%)
23-Jan-2026 10:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1630.00
Dr. Reddys Lab 1244.60
Cipla 1380.55
Zydus Lifesciences 889.90
Lupin 2152.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×